发布时间:
2026
-
07
-
16
China's life sciences industry has transformed into an innovation center of global significance, built upon accelerated regulatory pathways, strong policy support, and rapidly improving R&D efficiency across pharmaceuticals, medical devices, and biotechnology.Approximately 2,390 words | 5–6 min readFor a long time, China's innovative drug story was about the journey from "me-too" to "me-better." But halfway through 2026, the narrative has shifted—valuation is no longer driven by vision, but by hard metrics: pipeline data, deal values, and enrollment speed.KPMG...
浏览次数:4